Latest News and Press Releases
Want to stay updated on the latest news?
-
BOSTON, and DURHAM, N.C., Jan. 19, 2022 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance...
-
BOSTON, and DURHAM, N.C., Jan. 11, 2022 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance...
-
BOSTON, and Durham, N.C., Jan. 11, 2022 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance...
-
BOSTON and DURHAM, N.C., Jan. 06, 2022 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance...
-
EQT Private Equity and Goldman Sachs Asset Management committed to supporting Parexel’s Patients-First focus, track record of clinical excellence and dedication to qualityNewly-appointed Board of...
-
BOSTON and DURHAM, N.C., Oct. 20, 2021 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance...
-
BOSTON and DURHAM, N.C., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance...
-
Parexel leaders recognized as two of the 100 most inspiring people in life sciences for their transformative efforts to drive equity and innovation across the industry BOSTON and DURHAM, N.C., Aug. ...
-
BOSTON and DURHAM, N.C., July 28, 2021 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance...
-
BOSTON and DURHAM, N.C., July 22, 2021 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance...